HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Permanent cosmetics warning

This article was originally published in The Rose Sheet

Executive Summary

Swelling, peeling, blistering and scarring are among the more than 50 reported adverse events associated with permanent cosmetic ink shades sold by Arlington, Tex.-based Premier Products, according to FDA talk paper released July 2. Firm reported it would remove certain ink shades for lipliner, eyeliner and eyebrow color from the market following six adverse events last year, agency notes, but additional reports were obtained for shades that were not removed. FDA is conducting an ongoing investigation of the company. Tattoos, including permanent makeup, are considered cosmetics, and the pigment used in the inks are color additives that require premarket approval under the FD&C Act, FDA notes, but adds the agency has not traditionally regulated tattoo inks or pigments...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS012286

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel